BCRX Related StreetInsider.com Reports
-
BioCryst (BCRX) Hit Traders' Radars Again as China Bird Flu Death Toll Jumps Nearly 10%
-
BioCryst Pharmaceuticals, Inc. (BCRX) Posts Q1 Loss of 9c/Share
-
Trading Radar for 05/07: Electronic Arts (EA), DirecTV (DTV), Fossil (FOSL), McKesson (MCK) Report
-
BioCryst (BCRX) Moves Higher as WHO Calls H7N9 'Most Lethal' Bird Flu Strain
-
BioCryst Pharmaceuticals (BCRX) Lower Despite Rise in Bird Flu Death Toll
-
BioCryst (BCRX) Sees Upside; No Poultry Contact Reported in Large Amount of Bird Flu Cases
-
BioCryst Pharma (BCRX) Completes Type C Meeting w/ FDA; Requests pre-NDA
-
Unusual 11 Mid-Day Movers 04/12: (CLNT) (SBGI) (BCRX) Higher; (CRMB) (INFY) (ALVR) Lower
-
BioCryst (BCRX) Continues Higher on Latest Bird Flu Death
-
MLV & Co. Upgrades BioCryst Pharma (BCRX) to Buy
-
BioCryst Pharma (BCRX) Rally Overdone, Says Analyst
-
Unusual 11 Mid-Day Movers 04/08: (LUFK) (JKS) (STP) Higher; (NBG) (CRNT) (PVA) Lower
-
Streetinsider.com Pre-Open Movers 04/08: (LUFK) (BCRX) (PCYC) Higher; (DCTH) (OMPI) (BYI) Lower
-
Stocks Crossing 50-Day SMA 04/01: (BBRY) (ALXN) (SODA) Above; (CSCO) (ZNGA) (BCRX) Below
-
Unusual 11 Mid-Day Movers 04/01: (REFR) (SNFCA) (BCRX) Higher; (DLLR) (STP) (HDSN) Lower
-
StreetInsider.com Pre-Open Movers 4/01: (KWK) (TSLA) (VRNG) Higher; (AEGN) (PDM) (UAL) Lower (more...)
-
BioCryst (BCRX) Receives Prelim. Comment Letter from FDA for Peramivir
-
BioCryst Pharmaceuticals (BCRX) Initiates Phase 1 Trial of BCX4161 for HAE
-
BioCryst Pharmaceuticals, Inc. (BCRX) Posts Q4 Loss of 22c/Share
-
Trading Radar for 02/19: Dell (DELL), Yandex (YNDX), Marriott (MAR), La-Z-Boy (LZB), Allscripts (MDRX) Report
-
BBioCryst (BCRX) Terminates BCX5191 Preclinical in HCV
-
BioCryst Pharma (BCRX) Announces Restructuring; to Halve Workforce
-
Notable Mergers and Acquisitions of the Day 11/30: (BCRX) (KW)
-
BioCryst (BCRX), Presidio Announce Termination of Merger
-
JMP Securities Downgrades BioCryst Pharma (BCRX) to Market Perform
-
BioCryst Pharma's (BCRX) BCX4161 Put on Clinical Hold by FDA
-
BioCryst (BCRX) Issues Encouraging Update for BCX4430 on Yellow Fever
-
Top 10 Winners and Lowers for Q3 Earnings Season
-
Unusual 11 Mid-Day Movers 11/08: (DUSA) (RST) (PRMW) Higher; (CPRX) (BCRX) (PRSS) Lower
-
StreetInsider.com Pre-Open Movers 11/08: (DUSA) (WLL) (QCOM) Higher; (BCRX) (PANL) (SGEN) Lower (more...)
-
BioCryst Pharmaceuticals, Inc. (BCRX) Posts Q3 Loss of 19c/Share
-
Trading Radar for 11/08: Disney (DIS), Lannett (LCI), Allscripts (MDRX), Wendy's (WEN) Report
-
Unusual 11 Mid-Day Movers 10/31: (SHF) (WRC) (OPNT) Higher; (OXF) (WU) (CRNT) Lower
-
BioCryst (BCRX) Slammed After Withdrawing BCX5191 IND
-
BioCryst (BCRX) Withdraws IND for BCX5191 Following Talks with U.S. FDA
-
BioCryst (BCRX) to Merge With Presidio
-
BioCryst Pharma (BCRX) Tops Q2 EPS by 1c; Sees Increase in Net Operating Cash
-
Trading Radar for 08/02: Kraft (KFT), LinkedIn (LNKD), Teva Pharma (TEVA), Activision (ATVI) Report
-
BioCryst (BCRX) Reports Encouraging Data from BCX4208 Phase 2b in Gout
-
Morning Movers 07/13: (PLFE) (NWY) (AFFY) (SOL) Higher; (BPI) (TEU) (LXK) (AMPE) Lower
-
Bird Flu Back in Headlines AFter China Outbreak
-
Morning Movers 06/06: (LEE) (BCRX) (INVN) Higher; (TPX) (MFRM) (SCSS) (FCEL) Lower
-
BioCryst Pharmaceuticals (BCRX) Director Buys 20,000 Shares
-
BioCryst Pharmaceuticals (BCRX) to Present Three Posters on BCX4208 as Gout Treatment
-
Savient (SVNT) Shares Hit as BioCryst (BCRX) Gets FDA Guidance for Gout Treatment Approval
-
BioCryst Pharma (BCRX) Posts Narrower than Expected Q1 Loss of 13c/Share; Reaffirms
-
Morning Movers 03/13: (BBX) (MDS) (WOLF) (CKEC) Higher; (CCIX) (COOL) (BCRX) Lower
-
Pre-Open Movers 3/13 (MDS) (CKEC) (WOLF) Higher; (SB) (COOL) (XPO) Lower (more...)
-
BioCryst (BCRX) Seeks to Correct Erroneous Patent on HCV Inhibitor
-
BioCryst Pharmaceuticals, Inc. (BCRX) Reports In-Line Q4 EPS
Back to BCRX Stock Lookup
